4-Aminophenol

4-Aminophenol is a bifunctional aromatic compound carrying both an amine and a hydroxyl group on opposite ends of the benzene ring, a combination that makes it exceptionally reactive at both positions and, more specifically, makes it the direct chemical precursor of paracetamol (acetaminophen): a single acetylation of the amine group converts 4-aminophenol into the finished analgesic active pharmaceutical ingredient in one step. That one reaction is responsible for the overwhelming majority of global 4-aminophenol demand, making the compound's quality and purity profile a matter of direct pharmaceutical consequence rather than just an industrial convenience.

At room temperature it is a white to light tan crystalline powder that darkens slowly on prolonged exposure to air and light, owing to oxidation at the easily oxidised amine/hydroxyl pair — a sensitivity that governs how the material is packaged and stored far more than any acute hazard does. It is only slightly soluble in cold water but dissolves more readily in hot water and in common polar organic solvents.

Where it fits in the value chain

Pharmaceutical-intermediate-grade 4-aminophenol is acetylated with acetic anhydride to produce paracetamol API, the single largest global use of the compound by a wide margin. A smaller but still significant volume is consumed in photographic developer chemistry, where its combined amine/hydroxyl reactivity suits it to developing-agent synthesis, and in the manufacture of azo and sulphur dyes and rubber antioxidants, where the same bifunctional reactivity is put to different downstream use.

Grades we supply

Chelora Chemicals offers 4-Aminophenol in pharmaceutical-intermediate grade, meeting the assay, heavy-metal and related-substance specifications needed for paracetamol synthesis, and in technical grade for dye and rubber-chemical applications. Each grade is supplied with a batch-wise certificate of analysis.

4-Aminophenol is produced predominantly by catalytic hydrogenation of nitrobenzene under carefully controlled conditions: rather than reducing all the way through to aniline, the reaction is stopped at the partially reduced phenylhydroxylamine intermediate, which then undergoes an acid-catalysed rearrangement — the Bamberger rearrangement — that migrates the nitrogen-oxygen functionality to give 4-aminophenol directly. Controlling the hydrogenation to stop cleanly at the phenylhydroxylamine stage, without over-reducing to aniline or under-reducing to leave nitroso by-products, is the most demanding step in the whole route and the one that most determines yield and purity.

An alternative, older route reduces 4-nitrophenol directly to 4-aminophenol using iron and acid or catalytic hydrogenation, though the nitrobenzene/Bamberger route is now the dominant commercial process. Either way, the crude product is purified by recrystallisation to reach the assay and colour specification required of pharmaceutical-intermediate grade, since even small amounts of coloured oxidation by-products are unacceptable in material destined for paracetamol synthesis.